3 studies found for:    19108880 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Cost-effectiveness of Genotype Guided Treatment With Antiplatelet Drugs in STEMI Patients: Optimization of Treatment
Conditions: Myocardial Infarction;   STEMI
Intervention: Genetic: CYP2C19 genotyping
2 Terminated Genotype Guided Comparison of Clopidogrel and Prasugrel Outcomes Study
Condition: Cardiovascular Disease
Intervention:
3 Completed Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism
Condition: Myocardial Infarction
Interventions: Drug: cilostazol;   Drug: clopidogrel (Plavix);   Genetic: CYP2C19;   Drug: aspirin (Acetylsalicylic acid)

Indicates status has not been verified in more than two years